The poor penetration of topical burn agent through burn eschar on a porcine burn model [Letter to the Editor]
Wang, Xue-Qing, Hayes, Mark T., Kempf, Margit, Cuttle, Leila, Mill, Julie, & Kimble, Roy M. (2009) The poor penetration of topical burn agent through burn eschar on a porcine burn model [Letter to the Editor]. Burns, 35(6), pp. 901-902.
We read with great interest the article entitled “Enhancing drugs absorption through third-degree burn wound eschar” by Manafi et al. . The authors addressed the concern of poor penetration of topically applied anti-microbials through burn eschar and detailed the improvement of this penetration by penetration enhancers. Here, we would like to report the poor penetration of a topical agent into the viable deep dermal layer under burn eschar on a porcine burn model . In burn treatment, a common practice is the topical application of either anti-microbial products or wound enhancing agents. While the activity of anti-microbial products is designed to fight against microbes on the wound surface but with the least toxicity to viable tissue, wound enhancing agents need to reach the viable tissue layer under the burn eschar. Many studies have reported the accelerated healing of superficial burn wounds and skin graft donor sites by the topical application of exogeneous growth factors . It is well known that the efficacy of the penetration of a topical agent on intact skin mostly depends on the molecular size of the product  and . While burn injury destroys this epidermal physiological barrier, the coagulated burn tissue layer on the burn wound surface makes it difficult for topical agents to reach viable tissue....
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Administration, Cutaneous, Animals, Blood Proteins/*pharmacokinetics, Burns/*metabolism, Debridement, Disease Models, Animal, Female, Sus scrofa, alpha-2-HS-Glycoprotein|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2009 Elsevier|
|Copyright Statement:||This is the author’s version of a work that was accepted for publication in Burns. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Burns, [VOL 35, ISSUE 6, (2009)] DOI: 10.1016/j.burns.2008.08.022|
|Deposited On:||26 Feb 2014 23:13|
|Last Modified:||25 Mar 2014 04:44|
Repository Staff Only: item control page